Related Experiment Video
Updated: Sep 19, 2025

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Outcomes of acute severe ulcerative colitis at initial presentation
Diogo Couto Sousa1,2, Samuel Raimundo Fernandes1,2, Sofia Saraiva1,2
1Serviço de Gastrenterologia e Hepatologia, Hospital Santa Maria, Unidade Local de Saúde de Santa Maria, Lisboa.
Background:
20-25% of patients with ulcerative colitis (UC) will experience at least one episode of acute severe ulcerative colitis (ASUC). Up to 20% of nonresponders to medical treatment require surgery during the index episode. For approximately one-third of the patients, ASUC is the first manifestation of the disease, presenting unique challenges.
Methods And Aims:
Retrospective cohort study including 185 patients hospitalized with ASUC. We aim to compare the clinical outcomes between patients with new-onset and established UC.
Results:
62 (33.5%) patients had new-onset, while 123 (66.5%) had established UC. Demographic and baseline clinical characteristics were similar between groups. Patients with new-onset UC experienced longer hospitalizations (19 ± 22 vs. 12 ± 11 days; P = 0.002), longer delay until receiving rescue therapy [11 vs. 6 days (interquartile range : 6-8 days); P = 0.014] and more severe bacterial infections (16 vs. 4%; P = 0.005). We found no significant differences in steroid response ( P = 0.719), need for rescue therapy ( P = 0.522), response to rescue therapy ( P = 0.234), colectomy ( P = 0.655), mortality ( P = 0.516), and hospital readmission ( P = 0.929) between groups. After 1 year, colectomy or death occurred in 13.5% of patients. Independent predictors of adverse outcomes included active smoking, extensive colitis, the need for rescue therapy, and severe bacterial infections - but not new-onset disease.
Conclusion:
Major clinical outcomes were similar between patients with new-onset and established UC.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

